ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 239 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $6,554,000 | -31.4% | 162,159 | -2.3% | 0.09% | -32.1% |
| Q2 2015 | $9,549,000 | +31.8% | 165,926 | +45.8% | 0.13% | +17.5% |
| Q1 2015 | $7,246,000 | +48.3% | 113,807 | +43.8% | 0.11% | +54.1% |
| Q4 2014 | $4,885,000 | +42.9% | 79,125 | -10.1% | 0.07% | +39.6% |
| Q3 2014 | $3,418,000 | +66.4% | 88,030 | +47.6% | 0.05% | +65.6% |
| Q2 2014 | $2,054,000 | +2.6% | 59,626 | +28.7% | 0.03% | -5.9% |
| Q1 2014 | $2,002,000 | +1234.7% | 46,323 | +1059.8% | 0.03% | +1033.3% |
| Q3 2013 | $150,000 | -86.7% | 3,994 | -90.5% | 0.00% | -89.3% |
| Q2 2013 | $1,125,000 | – | 41,854 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,636,526 | $257,696,000 | 10.48% |
| WILLIAM HARRIS INVESTORS INC | 309,934 | $12,034,000 | 3.60% |
| DOWLING & YAHNKE LLC | 676,298 | $26,261,000 | 3.46% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 90,240 | $3,504,000 | 2.69% |
| HWG Holdings LP | 58,395 | $2,267,000 | 1.82% |
| Iguana Healthcare Management, LLC | 85,000 | $3,300,000 | 1.76% |
| PINNACLE ASSOCIATES LTD | 1,845,727 | $71,670,000 | 1.46% |
| Adamant Biomedical Investments AG | 140,000 | $5,436,000 | 1.36% |
| Apex Capital Management | 843,791 | $32,764,000 | 0.99% |
| PERKINS CAPITAL MANAGEMENT INC | 28,465 | $1,105,000 | 0.93% |